Correlation Between Collegium Pharmaceutical and KKR Co
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and KKR Co at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and KKR Co into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and KKR Co LP, you can compare the effects of market volatilities on Collegium Pharmaceutical and KKR Co and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of KKR Co. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and KKR Co.
Diversification Opportunities for Collegium Pharmaceutical and KKR Co
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Collegium and KKR is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and KKR Co LP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KKR Co LP and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with KKR Co. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KKR Co LP has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and KKR Co go up and down completely randomly.
Pair Corralation between Collegium Pharmaceutical and KKR Co
Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 1.14 times more return on investment than KKR Co. However, Collegium Pharmaceutical is 1.14 times more volatile than KKR Co LP. It trades about -0.03 of its potential returns per unit of risk. KKR Co LP is currently generating about -0.14 per unit of risk. If you would invest 3,071 in Collegium Pharmaceutical on November 27, 2024 and sell it today you would lose (189.00) from holding Collegium Pharmaceutical or give up 6.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Collegium Pharmaceutical vs. KKR Co LP
Performance |
Timeline |
Collegium Pharmaceutical |
KKR Co LP |
Collegium Pharmaceutical and KKR Co Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Collegium Pharmaceutical and KKR Co
The main advantage of trading using opposite Collegium Pharmaceutical and KKR Co positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, KKR Co can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KKR Co will offset losses from the drop in KKR Co's long position.Collegium Pharmaceutical vs. Phibro Animal Health | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Procaps Group SA | Collegium Pharmaceutical vs. Amphastar P |
KKR Co vs. Carlyle Group | KKR Co vs. Ares Management LP | KKR Co vs. Blackstone Group | KKR Co vs. Blue Owl Capital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance |